BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 22048975)

  • 1. Evidence that polymorphisms in detoxification genes modulate the susceptibility for sporadic medullary thyroid carcinoma.
    Barbieri RB; Bufalo NE; Secolin R; Silva AC; Assumpção LV; Maciel RM; Cerutti JM; Ward LS
    Eur J Endocrinol; 2012 Feb; 166(2):241-5. PubMed ID: 22048975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of cell cycle control genes influence the development of sporadic medullary thyroid carcinoma.
    Barbieri RB; Bufalo NE; Secolin R; Assumpção LV; Maciel RM; Cerutti JM; Ward LS
    Eur J Endocrinol; 2014 Dec; 171(6):761-7. PubMed ID: 25565272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genes of detoxification are important modulators of hereditary medullary thyroid carcinoma risk.
    Barbieri RB; Bufalo NE; Cunha LL; Assumpção LV; Maciel RM; Cerutti JM; Ward LS
    Clin Endocrinol (Oxf); 2013 Aug; 79(2):288-93. PubMed ID: 23278115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulatory Role of Single Nucleotide Polymorphisms of Distinct Genetic Pathways on Clinical Behavior of Medullary Thyroid Carcinoma.
    Mishra V; Kowtal P; Rane P; Sarin R
    Asian Pac J Cancer Prev; 2020 May; 21(5):1289-1293. PubMed ID: 32458635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive effect of RET polymorphisms on sporadic medullary thyroid carcinoma susceptibility and tumor aggressiveness.
    Ceolin L; Siqueira DR; Ferreira CV; Romitti M; Maia SC; Leiria L; Crispim D; Ashton-Prolla P; Maia AL
    Eur J Endocrinol; 2012 May; 166(5):847-54. PubMed ID: 22345297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [RET and GFRA1 germline polymorphisms in medullary thyroid cancer patients].
    Severskaia NV; Saenko VA; Il'in AA; Chebotareva IV; Rumiantsev PO; Isaev PA; Medvedev VS; Iasmita S
    Mol Biol (Mosk); 2006; 40(3):425-35. PubMed ID: 16813162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The RET polymorphic allele S836S is associated with early metastatic disease in patients with hereditary or sporadic medullary thyroid carcinoma.
    Siqueira DR; Romitti M; da Rocha AP; Ceolin L; Meotti C; Estivalet A; Puñales MK; Maia AL
    Endocr Relat Cancer; 2010 Dec; 17(4):953-63. PubMed ID: 20801952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the N-acetyltransferase 2 detoxification system in thyroid cancer susceptibility.
    Guilhen AC; Bufalo NE; Morari EC; Leite JL; Assumpcao LV; Tincani AJ; Ward LS
    Clin Cancer Res; 2009 Jan; 15(1):406-12. PubMed ID: 19118072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of a low prevalence of RAS mutations in a large medullary thyroid cancer series.
    Ciampi R; Mian C; Fugazzola L; Cosci B; Romei C; Barollo S; Cirello V; Bottici V; Marconcini G; Rosa PM; Borrello MG; Basolo F; Ugolini C; Materazzi G; Pinchera A; Elisei R
    Thyroid; 2013 Jan; 23(1):50-7. PubMed ID: 23240926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
    Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
    Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined RET and Ki-67 assessment in sporadic medullary thyroid carcinoma: a useful tool for patient risk stratification.
    Mian C; Pennelli G; Barollo S; Cavedon E; Nacamulli D; Vianello F; Negro I; Pozza G; Boschin IM; Pelizzo MR; Rugge M; Mantero F; Girelli ME; Opocher G
    Eur J Endocrinol; 2011 Jun; 164(6):971-6. PubMed ID: 21422198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking and susceptibility to thyroid cancer: an inverse association with CYP1A1 allelic variants.
    Bufalo NE; Leite JL; Guilhen AC; Morari EC; Granja F; Assumpcao LV; Ward LS
    Endocr Relat Cancer; 2006 Dec; 13(4):1185-93. PubMed ID: 17158763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma.
    Akulevich NM; Saenko VA; Rogounovitch TI; Drozd VM; Lushnikov EF; Ivanov VK; Mitsutake N; Kominami R; Yamashita S
    Endocr Relat Cancer; 2009 Jun; 16(2):491-503. PubMed ID: 19286843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in the initiators of RET (rearranged during transfection) signaling pathway and susceptibility to sporadic medullary thyroid carcinoma.
    Cebrian A; Lesueur F; Martin S; Leyland J; Ahmed S; Luccarini C; Smith PL; Luben R; Whittaker J; Pharoah PD; Dunning AM; Ponder BA
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6268-74. PubMed ID: 16091499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study of 69 genes in the ret pathway identifies low-penetrance loci in sporadic medullary thyroid carcinoma.
    Ruiz-Llorente S; Montero-Conde C; Milne RL; Moya CM; Cebrián A; Letón R; Cascón A; Mercadillo F; Landa I; Borrego S; Pérez de Nanclares G; Alvarez-Escolá C; Díaz-Pérez JA; Carracedo A; Urioste M; González-Neira A; Benítez J; Santisteban P; Dopazo J; Ponder BA; Robledo M;
    Cancer Res; 2007 Oct; 67(19):9561-7. PubMed ID: 17909067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide copy number analysis in a family with p.G533C RET mutation and medullary thyroid carcinoma identified regions potentially associated with a higher predisposition to lymph node metastasis.
    Araujo AN; Moraes L; França MI; Hakonarson H; Li J; Pellegrino R; Maciel RM; Cerutti JM
    J Clin Endocrinol Metab; 2014 Jun; 99(6):E1104-12. PubMed ID: 24601688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant association of TP53 Arg72Pro polymorphism in susceptibility to differentiated thyroid cancer.
    Khan MS; Pandith AA; Masoodi SR; Khan SH; Rather TA; Andrabi KI; Mudassar S
    Cancer Biomark; 2015; 15(4):459-65. PubMed ID: 25835179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of gender, age, and RET polymorphisms on C-cell hyperplasia and medullary thyroid carcinoma.
    Weinhaeusel A; Scheuba C; Lauss M; Kriegner A; Kaserer K; Vierlinger K; Haas OA; Niederle B
    Thyroid; 2008 Dec; 18(12):1269-76. PubMed ID: 18976163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of inherited genetic variants in ret proto-oncogene of Brazilian patients with apparently sporadic medullary thyroid carcinoma.
    Guerrero IM; Pessoa CH; Olmedo DB; Pontes ER; Matos LC; Tilli TM; Barcinski MA; Gimba ER
    Thyroid; 2006 Jan; 16(1):9-15. PubMed ID: 16487008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intronic single nucleotide polymorphisms in the RET protooncogene are associated with a subset of apparently sporadic pheochromocytoma and may modulate age of onset.
    McWhinney SR; Boru G; Binkley PK; Peczkowska M; Januszewicz AA; Neumann HP; Eng C
    J Clin Endocrinol Metab; 2003 Oct; 88(10):4911-6. PubMed ID: 14557473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.